Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer recurrent+38

Recruiting

InvestigationalNo placebo

Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Ds-3939A

Contact Research Centre

Breast cancer recurrent+2

Not recruiting

Registered drugNo placebo

Study on Restoring Immunotherapy Sensitivity in Advanced Triple Negative Breast Cancer Using Ceralasertib, Durvalumab, and Paclitaxel Albumin-Bound

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ceralasertib

Contact Research Centre

Breast cancer recurrent+7

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Breast cancer recurrent+2

Not recruiting

Registered drugNo placebo

Study of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Palbociclib

Contact Research Centre

Breast cancer recurrent+2

Not recruiting

Registered drugNo placebo

Study of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Carboplatin

Contact Research Centre

Breast cancer recurrent+2

Not recruiting

Registered drugNo placebo

Study Comparing Oral Paclitaxel (DHP107) and IV Paclitaxel for Patients with Recurrent or Metastatic HER2 Negative Breast Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Paclitaxel

Contact Research Centre

Find therapies in clinical trials near you

6 trials match your criteria

Breast cancer recurrent+38

Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

Breast cancer recurrent+2

Study on Restoring Immunotherapy Sensitivity in Advanced Triple Negative Breast Cancer Using Ceralasertib, Durvalumab, and Paclitaxel Albumin-Bound

Breast cancer recurrent+7

Study of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Breast cancer recurrent+2

Study of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery

Breast cancer recurrent+2

Study of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

Breast cancer recurrent+2

Study Comparing Oral Paclitaxel (DHP107) and IV Paclitaxel for Patients with Recurrent or Metastatic HER2 Negative Breast Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.